Clinical Trial Update: Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of once-daily CLS001 topical gel for rosacea has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• CLS001

Snippet

Sponsor: Maruho Co., Ltd. | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2022-07-08